Time (days)

Measurement

Intravenous

Subcutaneous

0

WBC G/AG N/M

12.40 (2.41) [9.0 - 15.0]^b

0.92  (0.24) [0.6 - 1.2]^b

0.15 (0.04) [0.10 - 0.21]^b

12.80 (2.39) [10.0 - 16.0]^bc

0.84 (0.27) [0.5 - 1.1]^bc

0.31 (0.33) [0.12 - 0.90]^a

1

WBC G/AG N/M

27.20 (5.07) [21.0 - 34.0]^a

2.62 (0.51) [2.0 - 3.3]^a

NS

25.60 (4.45) [20.0 - 31.0]^a

2.80 (0.54) [2.1 - 3.5]^a

NS

2

WBC G/AG N/M

26.20 (4.66) [21.0 - 32.0]^a

2.20 (0.57) [1.5 - 2.9]^a

NS

15.00 (4.74) [9.0 - 21.0]^b

1.30 (0.51) [0.7 - 1.9]^b

NS

3

WBC G/AG N/M

17.80 (6.01) [10.0 - 25.0]^b

1.20 (0.46) [0.4 - 1.6]^b

NS

11.20 (2.59) [5.0 - 15.0]^bc

0.68 (0.30) [0.3 - 1.1]^c

NS

4

WBC G/AG N/M

14.60 (2.07) [12.0 - 17.0]^b

0.78 (0.24) [0.5 - 1.1]^b

0.36 (0.08) [0.26 - 0.47]^a

9.20 (1.04) [8.0 - 10.5]^c

0.60 (0.16) [0.4 - 0.8]^c

0.23 (0.04) [0.18-0.29]^a

5

WBC G/AG N/M

14.00 (1.58) [12.0 - 16.0]^b

0.96 (0.21) [0.6 - 1.1]^b

0.40 (0.07) [0.30 - 0.49]^a

10.20 (1.30) [9.0 - 12.0]^c

0.70(0.16) [0.5 - 0.9]^c

0.27 (0.06) [0.20 - 0.36]^a

MSE LSD

WBC G/AG N/M

16.033 0.159 0.005

9.577 0.127 0.038